Abbott Again Moves To Block Generic Version Of Zemplar
In a suit launched in Delaware federal court, Abbott and partner Wisconsin Alumni Research Foundation accused Strides and subsidiary Agila Specialties Pvt. Ltd. of filing an abbreviated new drug application covering a Zemplar clone that infringes a trio of the plaintiffs' patents.
“Strides has committed and will commit acts of infringement of the patents-in-suit that...
To view the full article, register now.